Patent Granted for Simbionix Procedure Rehearsal Studioâ„¢
CLEVELAND, Ohio, August 10, 2011 /PRNewswire/ --
Simbionix USA Corporation, the world's leading provider of medical simulation training and education products for medical professionals and the healthcare industry, is pleased to announce it has been granted a patent in the UK for its innovative PROcedure Rehearsal Studio™.
The PROcedure Rehearsal Studio™  is a first in industry product, allowing clinicians to create patient specific 3D and 4D anatomical models based on a patient's imaging data, such as CT, for the purpose of simulating and planning endovascular procedures. The patent was granted on Simbionix's proprietary technology used in order to simulate an image guided angioplasty procedure based on input from a patient's 3D medical image, allowing a hands-on planning and rehearsal experience as well as providing physicians with unlimited generation of unique clinical case studies and the ability to better demonstrate a complex clinical procedure to their patients.
Earlier this year, the PROcedure Rehearsal Studio™ software was market cleared  in the United States, intended for use as a software interface and image segmentation system for the transfer of imaging data from a medical scanner to an output file. It is also intended as pre-operative software for simulating and evaluating surgical treatment options. Unique to the Simbionix simulation systems, the 3D segmentation model can be exported to the Simbionix ANGIO Mentor™ Simulator  practice environment. The results are an advanced method of creating an ever expanding library of modules for training and post-operative debriefing.
"This addition t